News | September 04, 2007

Clinical Trial Finds Success in Viatronix V3D-Colon

September 5, 2007 - Viatronix Inc., a developer of 3D imaging software and Vertec Scientific Ltd., its U.K. based distributor, jointly announced the publication of the results of a study utilizing Viatronix V3D Colon, performed at the Departments of Gastroenterology and Radiology, Hampstead Campus, Royal Free and University College Medical School in London, UK.

The results have been published in the September 2007 issue of Alimentary Pharmacology and Therapeutics, titled “Virtual versus Optical Colonoscopy in Symptomatic Gastroenterology Outpatients – the Case for Virtual Imaging Followed by Targeted Diagnostic or Therapeutic Colonoscopy.”

One hundred gastroenterology outpatients aged 50 and older underwent same day VC and OC. The endoscopists performing the OCs were unaware of the radiologist's report until the withdrawal phase of the endoscopy when segmental unblinding occurred. The VC and OC findings were compared using the unblinded OC as the reference standard. Extracolonic CT findings were also recorded.

Results:
Pancolonic endoluminal VC was achieved in 99 patients. OC caecal intubation was possible in 91 patients. Direct comparison was possible in 90 patients. Both techniques revealed two rectal and one hepatic flexure cancer. VC revealed 11 polyps ≥6 millimeters in diameter in 9 patients. First look OC revealed 10 polyps ≥6 millimeters in diameter in 9 patients with a further 15-millimeter polyp discovered after segmental unblinding. The abdominal CT scans revealed 175 extracolonic findings in 72 patients.

In symptomatic patients, 3D VC is equivalent to OC for diagnosing colon cancer and clinically significant polyps. In symptomatic patients, a case can be made for 3D VC as a primary imaging modality followed if necessary by same day targeted therapeutic or diagnostic OC.

For more information: www.viatronix.com

Related Content

Videos | Advanced Visualization | May 16, 2019
This is an example of how virtual reality is being used in neuro-radiology to better evaluate patients using advanced
Bioprinting research from the lab of Rice University bioengineer Jordan Miller featured a proof-of-principle — a scale-model of a lung-mimicking air sac with airways and blood vessels that never touch yet still provide oxygen to red blood cells.

Bioprinting research from the lab of Rice University bioengineer Jordan Miller featured a proof-of-principle — a scale-model of a lung-mimicking air sac with airways and blood vessels that never touch yet still provide oxygen to red blood cells. Image courtesy of Jordan Miller/Rice University.

News | Medical 3-D Printing | May 03, 2019
Bioengineers have cleared a major hurdle on the path to 3-D printing replacement organs with a breakthrough technique...
California Hospital Adds Machine-Vision Image Guided Surgery Platform to New Operating Suites
News | Advanced Visualization | April 26, 2019
Pickup Family Neurosciences Institute at Hoag in Newport Beach, Calif., announced the addition of the 7D Surgical...
Graphic courtesy of Pixabay

Graphic courtesy of Pixabay

Feature | Artificial Intelligence | April 22, 2019 | By Greg Freiherr
...
Technological Advancements Expected to Drive Virtual Reality Growth in Healthcare
News | Advanced Visualization | April 04, 2019
Increasing demand for innovative diagnostic techniques, neurological disorders and increasing disease awareness are...
Medivis Unveils AnatomyX Augmented Reality Education Platform
Technology | Advanced Visualization | April 02, 2019
Medical imaging and visualization company Medivis announced the launch of AnatomyX, its augmented reality (AR) platform...
Sponsored Content | Videos | Advanced Visualization | April 01, 2019
GE Healthcare goes beyond core equipment maintenance to help clients solve some of their most important asset and cli
Novarad Names New President
News | Enterprise Imaging | March 29, 2019
Medical imaging software company Novarad announced that it has appointed Paul Jensen as company president.